Member news and resources

ENDO 2013: ARE YOU READY?

Take advantage of the early-bird registration rates and start making your travel plans to the leading event for endocrinologists, ENDO 2013, in beautiful San Francisco, June 15-18. ENDO 2013 offers the ideal mix of education, networking, and a wide range of exhibits at ENDOExpo.

ENDO 2013 brings a number of new professional development opportunities this year and will feature four “Year In” sessions, which will provide reviews of the significant advances over the past year in the fields of genomics, thyroid cancer, neuroendocrinology, and G Protein-Coupled Receptors. Lynn Jorde, PhD, will highlight the ever-increasing role of genomics in understanding human health, while Steven Sherman, MD, will present new treatments and diagnostic approaches for thyroid cancer and Susan Smith, M.S., PhD, will review the newly discovered pieces of the puzzle that is the endocrine brain. Especially timely in view of the 2012 Nobel Prize in Chemistry, Graeme Milligan, PhD, FRSE, will offer a review of advances in GPCR research.

REGISTER TODAY:
www.endo-society.org/endo2013

VIEW THE ONLINE
SCIENTIFIC PROGRAM:
https://endo.confex.com/endo/2013endo/webprogram/programs.html

FLARE WORKSHOP BUILDS FUTURE LEADERS

Fourteen promising research fellows and graduate students recently received travel awards for the FLARE Workshop, held last month in San Diego. The Future Leaders Advancing Research in Endocrinology (FLARE) program helps trainees from underrepresented communities develop the essential leadership skills needed in order to have successful careers in biomedical research.

Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, the FLARE program provides participation in a structured leadership development network to highly motivated basic science and clinical research trainees who have demonstrated achievement in endocrine research. Learn more about the winners and the program at www.endosociety.org/FLARE.

NEW PUBERTY FACT SHEET
AVAILABLE

Puberty is a time of great emotional as well as physical change for any adolescent. When puberty comes late, it can be equally emotional for a child who is not growing and developing as quickly as his or her peers. The Hormone Health Network’s latest patient fact sheet, Delayed Puberty, defines this often hereditary condition and assures teens and parents that it’s most often a variant of normal development. While constitutional delay is the most common cause of delayed puberty, the fact sheet outlines underlying medical conditions that may also result in late onset puberty. Brief definitions and a list of suggested questions help patients have more informed conversations with their doctors. Visit www.hormone.org to download the fact sheet.

HEALTH DISPARITIES SUMMIT COMING TO BALTIMORE

Th is March, The Endocrine Society will bring together researchers, clinicians, healTheducators, and public and community health leaders who are dedicated to reducing health disparities. The inaugural Reducing Health Disparities Summit will be held at the Sheraton Baltimore Inner Harbor, March 22-23. Learn more or register at www.endo-society.org/disparities.

LEARN FROM PIONEERING ENDOCRINOLOGISTS

Now you can take a master lesson in the history of endocrinology from those who defined and refined the field. At the Clark T. Sawin Memorial Library and Resources Center website, you’ll find 40 oral and video history interviews from pioneering endocrinologists. New interviews were just added this year. Visit www.endo-society.org/about/sawin/histories.cfm.

REGISTER NOW
FOR ESAP™-ITE

Make certain your fellows and your program are on track by signing up!

Registration is now open for the ESAP In-Training Exam 2013 (ESAP-ITE), the premier online exam for fellows. In addition to the unique opportunity to assess your clinical training program, ESAP-ITE now delivers enhanced features that make it easier to manage your program’s engagement.

The improved interface lets you:
• Easily register fellows and update existing registrations.
• Monitor progress of fellows through a new reporting feature.
• View data from previous years of ESAP-ITE for a multi-year view of your program’s performance.
To learn more or register
for ESAP-ITE, visit www.endoselfassessment.org/ite.aspx.

IN MEMORIAM

Dr. Elwood Jensen, who served as president of The Endocrine Society June 1980-June 1981, died Dec. 16, 2012, in Cincinnati. Jensen earned the Society’s Fred Conrad Koch Award in 1984, the highest honor bestowed by the Society, for his pioneering research in hormone receptors, which opened the door to new life-saving treatments for breast cancer. Jensen’s work led to the establishment of biochemical “receptors” as a new field of scientific research, leading to many more medical breakthroughs.

“Jensen’s revolutionary research has saved lives and his discovery of estrogen receptors is clearly one of the highest achievements in the field of endocrinology,” says Scott Hunt, executive director and CEO of The Endocrine Society. “He will be greatly missed.”

Jensen served as the George J. and Elizabeth Wile Chair in Cancer Research at the University of Cincinnati and the Charles B. Huggins Distinguished Service Professor Emeritus in the Ben May Department for Cancer Research and the Department of Biochemistry and Molecular Biology at the University of Chicago. Additional honors bestowed upon Jensen during his distinguished career include the 2004 Albert Lasker Medical Research Award and multiple nominations for the Nobel Prize.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in